Quality of life ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mood ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in all serious adverse events compared with placebo/open control (high certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death from any cause compared with placebo/open control (high certainty).
1 finding from 1 review
Mean quality of life ‐ health utility · adults with acute spontaneous intracerebral haemorrhage
1 finding from 1 review
Mood · adults with acute spontaneous intracerebral haemorrhage
1 finding from 1 review
Cognitive function · adults with acute spontaneous intracerebral haemorrhage
1 finding from 1 review
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (high certainty).
1 finding from 1 review
Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) leads to lower intracerebral haemorrhage expansion by 24 hours compared with placebo/open control (high certainty).
1 finding from 1 review
Analgesia requirements · live donor nephrectomy (primary outcomes)
1 finding from 1 review
Duration of procedure · live donor nephrectomy (primary outcomes)
1 finding from 1 review
Blood loss · live donor nephrectomy (primary outcomes)
1 finding from 1 review
Incidence of perioperative complications · live donor nephrectomy (primary outcomes)
Summary of findings table ‐ Laparoscopic showed no clear difference in perioperative Complications compared with hand‐assisted (low certainty).
1 finding from 1 review
Reoperation · live donor nephrectomy (primary outcomes)
Summary of findings table ‐ Laparoscopic showed no clear difference in reoperations compared with hand‐assisted (low certainty).
1 finding from 1 review
Warm ischaemia time · live donor nephrectomy (primary outcomes)
1 finding from 1 review
Length of hospital stay · live donor nephrectomy (primary outcomes)
1 finding from 1 review
Early graft loss ‐ not reported · live donor nephrectomy (primary outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Delayed graft function ‐ not reported · live donor nephrectomy (primary outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute rejection ‐ not reported · live donor nephrectomy (primary outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found